Korean Journal of Acupuncture

Society for Meridian and Acupoint (경락경혈학회)
권호 표지
DOI QR코드

DOI QR Code

A Case Report of Long-term Acupuncture Treatment in Bortezomib Induced Peripheral Neuropathy

보르테조밉으로 유발된 말초신경병증에 대한 장기간의 침치료 증례 보고

  • Kim, So Yeon (School of Korean Medicine, Pusan National University) ;
  • Choi, Jun Yong (School of Korean Medicine, Pusan National University) ;
  • Yun, Young Ju (School of Korean Medicine, Pusan National University) ;
  • Park, Seong Ha (School of Korean Medicine, Pusan National University) ;
  • Han, Chang Woo (School of Korean Medicine, Pusan National University)
  • 김소연 (부산대학교 한의학전문대학원) ;
  • 최준용 (부산대학교 한의학전문대학원) ;
  • 윤영주 (부산대학교 한의학전문대학원) ;
  • 박성하 (부산대학교 한의학전문대학원) ;
  • 한창우 (부산대학교 한의학전문대학원)
  • Received : 2015.10.29
  • Accepted : 2015.11.30
  • Published : 2015.12.27
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : We present a successful administration of acupuncture in alleviating persistant peripheral neuropathy due to bortezomib, a potent therapeutic agent of mutlple myeloma. Methods : A patient, experiencing numbness, coldness, tingling and weakness in her feet and hands after bortezomib treatment, was administered acupuncture for 32 weeks, 3 times/week for first 4 weeks and 2 times/week the last 28 weeks, in bilateral acupuncture points, ST36, ST40, EX-LE10, LI11, TE5, and EX-UE9. Responses were assessed at the end of every 4 weeks with Eastern Cooperative Oncology Group(ECOG) grading system, National Cancer Institute - Common Toxicity Criteria(NCIC-CTC) v4.0, Numeric Rating Scale(NRS) 0-10, and Neuropathy Pain Scale (NPS). Results : ECOG was improved from 2 to 1, NCIC-CTC from 2 to 1, NRS from 8 to 1, and NPS from 41 to 5 through 32 weeks of acupuncture treatment. Conclusions : It is conceivable that acupuncture can be a help to relieve bortezomib induced peripheral neuropathy.

Keywords

References

  1. Becker N. Epidemiology of multiple myeloma. Recent Results Cancer Res. 2011 ; 183 : 25-35. https://doi.org/10.1007/978-3-540-85772-3_2
  2. Argyriou AA, Iconomou G, Kalofonos HP. Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature. Blood. 2008 ; 112(5) : 1593-9. https://doi.org/10.1182/blood-2008-04-149385
  3. Cavaletti G, Jakubowiak AJ. Peripheral neuropathy during bortezomib treatment of multiple myeloma: a review of recent studies. Leuk Lymphoma. 2010 ; 51(7) : 1178-87. https://doi.org/10.3109/10428194.2010.483303
  4. Cata JP, Weng HR, Burton AW, Villareal H, Giralt S, Dougherty PM. Quantitative sensory findings in patients with bortezomib- induced pain. J Pain. 2007 ; 8(4) : 296-306. https://doi.org/10.1016/j.jpain.2006.09.014
  5. Bao T, Zhang R, Badros A, Lao L. Acupuncture treatment for bortezomib-induced peripheral neuropathy: a case report. Pain Res Treat. 2011 ; 2011 : 920807.
  6. Mandiroglu S, Cevik C, Ayli M. Acupuncture for neuropathic pain due to bortezomib in a patient with multiple myeloma. Acupunct Med. 2014 ; 32(2) : 194-6. https://doi.org/10.1136/acupmed-2013-010491
  7. Bao T, Medeiros M, Zhang R, Dorsey SG, Badros A. Improvement of Painful Bortezomib-Induced Peripheral Neuropathy Following Acupuncture Treatment in a Case Series of Multiple Myeloma Patients. Med Acupunct. 2012 ; 24(3) : 181-7. https://doi.org/10.1089/acu.2011.0868
  8. Bao T, Goloubeva O, Pelser C, Porter N, Primrose J, Hester L, et al. A pilot study of acupuncture in treating bortezomib-induced peripheral neuropathy in patients with multiple myeloma. Integr Cancer Ther. 2014 ; 13(5) : 396-404. https://doi.org/10.1177/1534735414534729
  9. Eastern Cooperative Oncology Group. ECOG Performance Status. [cited 2015 Oct 25]. Available from: http://ecog-acrin.org/resources/ecog-performance-status
  10. National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) v4.0. [cited 2015 Oct 25]. Available from: http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf
  11. National Institutes of Health - Warren Grant Magnuson Clinical Center. Pain Intensity Instruments. [cited 2015 Oct 25]. Available from: http://www.webcitation.org/6Ag75MDIq
  12. Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology. 1997 ; 48(2) : 332-8. https://doi.org/10.1212/WNL.48.2.332
  13. Han Y, Smith MT. Pathobiology of cancer chemotherapy- induced peripheral neuropathy (CIPN). Front Pharmacol. 2013 ; 4 : 156.
  14. Wong R, Sagar S. Acupuncture treatment for chemotherapy- induced peripheral neuropathy--a case series. Acupuncture in medicine. 2006 ; 24(2) : 87-91. https://doi.org/10.1136/aim.24.2.87
  15. Donald GK, Tobin I, Stringer J. Evaluation of acupuncture in the management of chemotherapy-induced peripheral neuropathy. Acupunct Med. 2011 ; 29(3) : 230-3. https://doi.org/10.1136/acupmed.2011.010025
  16. Schroeder S, Meyer-Hamme G, Epplee S. Acupuncture for chemotherapy- induced peripheral neuropathy (CIPN): a pilot study using neurography. Acupunct Med. 2012 ; 30(1) : 4-7. https://doi.org/10.1136/acupmed-2011-010034
  17. Yoon J, Jeon JH, Lee YW, Cho CK, Kwon KR, Shin JE, et al. Sweet bee venom pharmacopuncture for chemotherapy-induced peripheral neuropathy. J Acupunct Meridian Stud. 2012 ; 5(4) : 156-65. https://doi.org/10.1016/j.jams.2012.05.003
  18. Rostock M, Jaroslawski K, Guethlin C, Ludtke R, Schroder S, Bartsch HH. Chemotherapy-induced peripheral neuropathy in cancer patients: a four-arm randomized trial on the effectiveness of electroacupuncture. Evid Based Complement Alternat Med. 2013 ; 2013 : 349653.
  19. Franconi G, Manni L, Schroder S, Marchetti P, Robinson N. A systematic review of experimental and clinical acupuncture in chemotherapy-induced peripheral neuropathy. Evid Based Complement Alternat Med. 2013 ; 2013 : 516916.
  20. Han CW. Acupuncture in chemotherapy-induced peripheral neuropathy : a review. Journal of PNU Korean Medicine Hospital. 2014 ; 3 :1-6.

Cited by

  1. 항암화학요법으로 인한 백혈구감소증 환자의 침 치료 증례 보고 vol.38, pp.5, 2015, https://doi.org/10.22246/jikm.2017.38.5.806
  2. 항암제 유발 말초신경병증 한의 치험 2례 vol.24, pp.2, 2015, https://doi.org/10.15432/jkto.2019.24.2.023